Documentos de Académico
Documentos de Profesional
Documentos de Cultura
207.thor Gel
207.thor Gel
D-DT-01 v. 01
HOJA DE SEGURIDAD
THOR GEL
120%5( 3$5$5$<266$&
',5(&&,Ï1 3URORQJDFLyQ/XFDQDV/D9LFWRULD
7(/e)212
RIESGOS:
(O FRQWHQLGRGHODVEROVDVSRUVHSDUDGRSXHGHFDXVDULUULWDFLyQSDUDORV RMRV SLHO \
PHPEUDQDVPXFRVDV
/DVREUHH[SRVLFLyQSXHGHDIHFWDUHOKtJDGRORVULxRQHV\HOWUDFWRJDVWURLQWHVWLQDO
/DV SHUVRQDV FRQ PROHVWLDV FUyQLFDV WDQWR UHVSLUDWRULDV FRPR FXWiQHDV SRGUtDQ YHU
LQFUHPHQWDGRHOULHVJRIUHQWHDXQDH[SRVLFLyQFRQWLQXD
Página 1 de 6
Vigente desde: 09/01/15 Última revisión: 03/04/18
01 / 08 / 2018
D-DT-01 v. 01
(O7+25*(/ HV SURGXFWR GH XQD UHDFFLyQ TXtPLFDHQWUH VXV FRPSRQHQWHV 1R HV XQD
PH]FOD GH ODV VXVWDQFLDV TXH OR FRPSRQHQ HV GHFLU pVWDV SLHUGHQ VXV SURSLHGDGHV
RULJLQDOHVSDUDIRUPDUHOQXHYRSURGXFWRTXHHVHO*(/DSOLFDGRHQHOVXHOR
$OPDFHQDUORHQXQOXJDUIUHVFRVHFR\YHQWLODGR3URWHJHUORFRQWUDGDxRItVLFR$LVODUGH
VXVWDQFLDVLQFRPSDWLEOHV
0DQWpQJDORIXHUDGHODOFDQFHGHORVQLxRV
)XHUD GH VX HPSDTXH RULJLQDO PDQWHQHUOR HQ XQ UHFLSLHQWH FHUUDGR KHUPpWLFDPHQWH FDGD
FRQWHQLGRGHEROVDSRUVHSDUDGRSDUDHYLWDUODUHDFFLyQHQVHFR
(QHODOPDFHQDMHQRVHGHEHDSLODUPiVGHFDMDVGHSURGXFWR
/RV XWHQVLOLRV XVDGRV HQ OD SUHSDUDFLyQ GHO 7+25*(/ FRPR VRQ ORV FRQWHQHGRUHV \
UHPRYHGRUHVGHEHQVHUGHSOiVWLFRRPDGHUDSDUDHYLWDUODFRQWDPLQDFLyQRDOWHUDFLyQGHOD
FRPSRVLFLyQGHODVVROXFLRQHVDFXRVDVDSUHSDUDU
6H GHEHQ XWLOL]DU XWHQVLOLRV SRU VHSDUDGR SDUD OD SUHSDUDFLyQ GH FDGD VROXFLyQ D ILQ GH
HYLWDUODIRUPDFLyQGHJHOHQORVUHFLSLHQWHV
)LQDOPHQWHHQMXDJXHELHQWRGRPDWHULDOXWLOL]DGR
/RV HQYDVHV GH HVWH PDWHULDO SXHGHQ VHU SHOLJURVRV FXDQGR HVWiQ YDFtRV \D TXH UHWLHQHQ
UHVLGXRV GHO SURGXFWR SROYR VyOLGRV REVHUYDU WRGDV ODV DGYHUWHQFLDV \ SUHFDXFLRQHV
LQGLFDGDVSDUDHOSURGXFWR
4.3 RECOMENDACIONES
9HUWHUHOFRQWHQLGRGHODVEROVDVORPiVFHUFDSRVLEOHDORVUHFLSLHQWHVGRQGHVHSUHSDUDQ
ODVVROXFLRQHVDFXRVDVDILQGHHYLWDUSpUGLGDGHSURGXFWR
Página 2 de 6
Vigente desde: 09/01/15 Última revisión: 03/04/18
01 / 08 / 2018
D-DT-01 v. 01
$3$5,(1&,$ *HOFRORUPDUUyQDYHUGHGHSHQGLHQGRGHOPHGLR
3(6202/(&8/$5
38172'()86,Ï1 1RGHWHUPLQDGR
38172'(&21*(/$0,(1721RGHWHUPLQDGR
38172'((%8//,&,Ï11RGHWHUPLQDGR
5$1*2S+
62/8%,/,'$'(1$*8$ ,QVROXEOH
'(16,'$'$3$5(17( ± SROYRVHFR
±JP/ JHOIRUPDGR
2/25 ,QRGRUR
3DUDODSUHSDUDFLyQGHODVVROXFLRQHVVHUHFRPLHQGDHOXVRGHJXDQWHVGHVHFKDEOHV\DTXH
DOFRQWDFWRFRQODSLHOSRUXQDPSOLRSHULRGRGHWLHPSR\GHDFXHUGRDODVHQVLELOLGDGGHOD
PLVPDSRGUtDRFDVLRQDUHQURMHFLPLHQWR
([LVWH XQ ULHVJR PtQLPR DO SUHSDUDU \ YHUWHU DO WHUUHQR ODV VROXFLRQHV SRU OR TXH VH
UHFRPLHQGDXVDUOHQWHVDSUXHEDGHVDOSLFDGXUDV
'LFKDVFRQVLGHUDFLRQHVVRQSDUDFRPSRQHQWHV\SURGXFWRIRUPDGR
0
Componente crema (2) 2 0
0
Producto Formado (1 + 2) 0 0
Página 3 de 6
Vigente desde: 09/01/15 Última revisión: 03/04/18
01 / 08 / 2018
D-DT-01 v. 01
8.1 ESTABILIDAD:
'HORV&RPSRQHQWHV(VWDEOHEDMRODVFRQGLFLRQHVGHDOPDFHQDPLHQWRUHFRPHQGDGDV
'HO3URGXFWRIRUPDGR(VWDEOH
D )UHQWH D XQ iFLGR PLQHUDO FRQFHQWUDGR \ HQ HEXOOLFLyQ SRGUtD OLEHUDU +&1 FRQ OD
VXEVLJXLHQWH IRUPDFLyQ GH FLDQXURV FRQGLFLRQHV TXH QR VH WLHQHQ EDMR WLHUUD DO
SUHSDUDUOR
E 6HGHVFRPSRQHHQSUHVHQFLDGHH[FHVRGHVROXFLyQGHDPRQLDFRRKLGUy[LGRGHVRGLR
FRQFHQWUDGRSHURHQQLQJXQRGHORVFDVRVKD\IRUPDFLyQGHFLDQXURV
9. PRIMEROS AUXILIOS
Inhalación: 'H SHUFLELU VtQWRPDV WUDVODGDUVH DO DLUH IUHVFR \ HQ FDVR GH VHU QHFHVDULR
SXHGHXVDUR[tJHQR6LORVVtQWRPDVSHUVLVWHQFRQVHJXLUDWHQFLyQPpGLFD
Ingestión: (QMXDJDU OD ERFD FRQ DJXD 1R LQGXFLU DO YyPLWR D PHQRV TXH WHQJD
LQGLFDFLRQHVGHOSHUVRQDOPpGLFR1RGDUQDGDSRUYtDRUDO VLODSHUVRQDHVWiLQFRQVFLHQWH
&RQVHJXLUDWHQFLyQPpGLFDLQPHGLDWDPHQWH
Contacto con los ojos: /DYDU ORV RMRV LQPHGLDWDPHQWH FRQ DEXQGDQWH DJXD GXUDQWH DO
PHQRV PLQXWRV DEULHQGR \ FHUUDQGR ORV SiUSDGRV RFDVLRQDOPHQWH 6L XVD OHQWHV GH
FRQWDFWR TXtWHVHORV \ VLJD ODYDQGR GXUDQWH PLQXWRV 6L GHVDUUROOD R SHUVLVWH XQD
LUULWDFLyQFRQVLJDDWHQFLyQPpGLFD
Ingestión:1RVHKDUHJLVWUDGRLQJHVWDRUDOSRUORFXDOQRVHWLHQHQGDWRVFOtQLFRV
Inhalación:(OSURGXFWRHVXQJHO1RDSOLFD
Página 4 de 6
Vigente desde: 09/01/15 Última revisión: 03/04/18
01 / 08 / 2018
D-DT-01 v. 01
Ojos: 3XHGHSURYRFDULUULWDFLyQ
Piel: 3XHGHSURYRFDULUULWDFLyQ
Inhalación: /RVSROYRVGHHVWHSURGXFWRSXHGHQFDXVDUODLUULWDFLyQGHQDUL]JDUJDQWD\
YtDVUHVSLUDWRULDV
Ingestión: 3XHGHSURYRFDUPDOHVWDUHVWRPDFDOQiXVHDVRYyPLWRV
Cancerígeno1R
Carcinógeno : 1R
Mutagénico : 1RGHWHUPLQDGR
Riesgo De Incendio1RVHHQFHQGHUi
Riesgos especiales3URGXFWR$OFDOLQR
Cancerígeno1RGHWHUPLQDGR
Carcinógeno: 1RGHWHUPLQDGR
Mutagénico: 1RGHWHUPLQDGR
(OSURGXFWRQRHVFRQVLGHUDGRFRPRSHOLJURVRSDUDHOWUDQVSRUWH.
86((48,323527(&725$3523,$'2
12.1 ACCIÓN CORRECTIVA: 5HFRMHU HO SURGXFWR GHUUDPDGR VLQ OHYDQWDU SROYR /XHJR
DSOLFDUXQFKRUURGHDJXDDORVGHUUDPHVSHTXHxRVFRQGXFLpQGRORDOGUHQDMHVDQLWDULR
Página 5 de 6
Vigente desde: 09/01/15 Última revisión: 03/04/18
01 / 08 / 2018
D-DT-01 v. 01
12.2 DESPERDICIOS:&RQVXOWHODVQRUPDVORFDOHVTXHHVWDEOHFHQORVOtPLWHVSDUDSURGXFWRV
TXtPLFRV
/RV GHVHFKRV \ UHVLGXRV GHO SURGXFWR GHEHUiQ PDQHMDUVH GH DFXHUGR D OD UHJODPHQWDFLyQ
DPELHQWDOORFDORQDFLRQDOYLJHQWH
/RVXVXDULRVWLHQHQODUHVSRQVDELOLGDGGHHYDOXDU\XVDUHVWHSURGXFWRFRQVHJXULGDG\FXPSOLU
FRQWRGDVODVOH\HV\UHJODPHQWRVDSOLFDEOHVHQVXVUHVSHFWLYDVORFDOLGDGHV
(O &yGLJR 1DFLRQDO GH (OHFWULFLGDG HQ OD VHFFLyQ GH 0pWRGRV GH 3XHVWD D 7LHUUD UHJOD
%LQGLFDTXHVHSXHGHQHPSOHDUWUDWDPLHQWRVTXtPLFRVRVXHORVDUWLILFLDOHVSDUDGLVPLQXLU
ODUHVLVWHQFLDGHSXHVWDDWLHUUDORVFXDOHVGHEHQVHUDFHSWDEOHV\FHUWLILFDGRVSRUXQDHQWLGDG
HVSHFLDOL]DGDHLPSDUFLDOFRPSHWHQWHDVHJXUiQGRVHTXHGLFKRVWUDWDPLHQWRVQRDWHQWHQFRQWUD
HOPHGLRDPELHQWH
/DLQIRUPDFLyQSURSRUFLRQDGDSRU3$5$5$<266$&HQHVWDKRMDGHVHJXULGDGFRQVWLWX\H
XQUHVXPHQ~WLOGHORVSHOLJURVGHO*HOHQODIRUPDHQODTXHJHQHUDOPHQWHVHXVDGHVGHORV
SXQWRVGHYLVWD$PELHQWDO\GH3UHYHQFLyQGH5LHVJRV/DERUDOHV(QFXDOTXLHUFDVRODILFKD
GHVHJXULGDGQRSXHGHSUHYHU\SURSRUFLRQDUWRGDODLQIRUPDFLyQTXHSXHGDVHUQHFHVDULDSDUD
WRGDVODVVLWXDFLRQHV
/D SUHVHQWH +RMD GH 6HJXULGDG VH EDVD HQ OD H[SHULHQFLD H LQIRUPDFLyQ WpFQLFD TXH VH
FRQVLGHUD FRQILDEOH &DEH UHVDOWDU TXH WRGR GDWR YHUWLGR HQ OD SUHVHQWH KRMD HVWi VXMHWR D
FRQVWDQWH UHYLVLyQ \ DFWXDOL]DFLyQ FRQIRUPH VH JHQHUHQ QXHYRV FRQRFLPLHQWRV \ VH REWHQJD
PiVH[SHULHQFLD
(ODERUDGRSRU$QD*DUFtD7XOLFK%CQP650
$SUREDGRSRU9LFHQWH&DEUHMRV3RODVWUL
Página 6 de 6
Vigente desde: 09/01/15 Última revisión: 03/04/18